Fig. 8.
Fig. 8. Time course of percentage of CD3+ T cells expressing HLA-DR antigen, a marker of activated T cells, during chemotherapy and 1 year of follow-up.

Time course of percentage of CD3+ T cells expressing HLA-DR antigen, a marker of activated T cells, during chemotherapy and 1 year of follow-up.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal